Table 1.
Baseline characteristics of patients in this study
| Parameters | All patients (n = 61) | Selected patients (n = 47) |
|---|---|---|
| Male, n (%) | 47 (77.05) | 35 (74.47) |
| Age (years), mean ± SD | 36.13 ± 11.28 | 38.36 ± 11.35 |
| BMI (kg/m2), mean ± SD | 24.42 ± 3.48 | 24.48 ± 3.40 |
| CHB, n (%) | 57 (93.44) | 44 (93.62) |
| ALT >2 × ULN, n (%) | 42 (68.85) | 33 (70.21) |
| HBV DNA level (log10 IU/ml), mean ± SD | 6.92 ± 1.61 | 6.91 ± 1.69 |
| HBsAg (log10 IU/ml), mean ± SD | 3.88 ± 0.74 | 3.85 ± 0.76 |
| HBeAg-positive patients, n (%) | 51 (83.61) | 38 (80.85) |
| HBV genotype, n (%) | ||
| B | 8 (13.11) | 5 (10.64) |
| C | 27 (44.26) | 23 (48.94) |
| Undetermined | 26 (42.62) | 19 (40.42) |
BMI: Body mass index; CHB: Chronic hepatitis B; ALT: Alanine aminotransferase; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; ULN: Upper normal limit; SD: Standard deviation.